BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

JHP Pharmaceuticals Enters Agreement to Produce Life-Saving Drug


7/7/2011 8:00:55 AM

PARSIPPANY, N.J., July 7, 2011 /PRNewswire/ --JHP Pharmaceuticals, a leading provider of contract manufacturing services for sterile injectable products has entered into an agreement with an undisclosed pharmaceutical company. The agreement is for the product transfer and registration batch production of a life-saving drug.

Commenting on JHP's selection, Stuart Hinchen, CEO and President of JHP noted, "Our cGMP compliance record and experienced staff allow us to effectively serve this important customer. JHP's history of manufacturing DEA-regulated products is vital in producing this terminally sterilized life-saving drug. We see this partnership as another opportunity to demonstrate our customer-focused approach in the manufacture of quality-driven products that save patient lives."

Hinchen also noted, "During the last six months, we successfully completed FDA and EMA audits in addition to entering agreements with four new contract customers. Our continued investment in our people and our facility has resulted in an internal infrastructure that supports ongoing sustainable growth."

JHP's Rochester, Michigan manufacturing site has a solid history of successful partnerships, manufacturing clinical and commercial products.

About JHP Pharmaceuticals, LLC

JHP Pharmaceuticals, headquartered in New Jersey, provides contract manufacturing of sterile injectables and ophthalmic/otic products, for large and small pharmaceutical and biotech organizations.

JHP's sterile manufacturing facility, located in Rochester Michigan sits on over 80 acres of land and includes a 171,000 sq. ft. production building and warehouse. The production facility utilizes three high-speed filling lines, a clinical filling line, four lyophilizers and an ophthalmic filling line. The site also includes separate facilities for chemistry, sterility testing, and analytical methods development.

JHP has the capability to manufacture small-scale clinical through large-scale commercial products. JHP employs more than 330 staff in the USA in its manufacturing, product development, sales & marketing and corporate areas. For more information, please visit www.jhppharma.com.

Contact:

Dan Leone
973.658.3559

Bill Conway
877.906.7556

SOURCE JHP Pharmaceuticals



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES